Aktuelle Kurse von AEON Biopharma, Inc. Class A Common Stock

Börse	Ticker	Währung	Letzter Umsatz	Kurs	Tagesveränderung
NYSE	AEON	USD	09.06.2025 23:59	0,89 USD	0,79 USD +11,99 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	58,76 %	85,92 %	34,85 %	-98,10 %	-99,26 %	-99,87 %

Company Profile for AEON Biopharma, Inc. Class A Common Stock Share

AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.

Company Data

Name AEON Biopharma, Inc. Class A Common Stock

Company AEON Biopharma, Inc.

Symbol AEON

Website http://www.aeonbiopharma.com

Primary Exchange

NYSE

ISIN US00791X1000

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Jost Fischer

Country United States of America

Currency USD

Employees 0,0 T

Address 4040 Macarthur Boulevard, 92614 Newport Beach

IPO Date 2023-07-24

Stock Splits

Date	Split
26.02.2025	1:72

Ticker Symbols

Name	Symbol
NYSE	AEON

More Shares

Investors who AEON Biopharma, Inc. Class A Common Stock hold also have the following shares in their portfolio:

AMERIC.TOWER 21/27 Bond

PRIM SA EO-,25 Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog